The Health Department has
opened public submissions for a
consultation on the draft terms of
reference for post-market-reviews
of COPD medicines and ezetimibe,
looking at their utilisation, safety,
efficacy and cost-effectiveness.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 19 Oct 15
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Oct 15
